CHARTWELL RX LLC
- CONGERS, NY 10920-1307
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $283.6M
- Awards on record
- 601
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
CHARTWELL RX LLC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About CHARTWELL RX LLC
- Headquarters
- CONGERS, NY 10920-1307
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIER5UA9TYBGH4
- CAGE8APG0
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $283.6M
- Awards on record
- 601
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response · Defense Logistics Agency
25 most recent of 601 awards
75A50326C00010
Recompete 6–12 mo: Potential end Sep 29, 2027 (10 months away)BULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (CHARTWELL RX, LLC)
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $21.9M
- Period of performance
- Sep 30, 2026 – Sep 29, 2027
75A50325F80009
Recompete 6–12 mo: Potential end Jun 22, 2027 (7 months away)DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $144.6M
- Period of performance
- Jun 23, 2025 – Jun 22, 2027
SPE2D026F0099
Recompete < 6 mo: Potential end Apr 19, 2027 (5 months away)8511936905!OTHER MEDICAL
Department of Defense · Defense Logistics Agency
- Obligated
- $648.6K
- Period of performance
- Feb 27, 2026 – Apr 19, 2027
75A50325C00012
Completed: Period of performance ended Aug 31, 2026BULK PHARMA - GROUP A (ASSET MGMT) DOXYCYCLINE 25MG/5ML ORAL SUSPENSION, POWDER, 60ML BOTTLE, ONDANSETRON HCL 8MG, 30 TABLETS, BOTTLE
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $16.1M
- Period of performance
- Sep 1, 2025 – Aug 31, 2026
SPE2D326F287Q
Completed: Period of performance ended Jul 23, 20264572451958!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $550.8
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F289E
Completed: Period of performance ended Jul 23, 20264572455482!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $550.5
- Period of performance
- Jul 22, 2026 – Jul 23, 2026
SPE2D326F282N
Completed: Period of performance ended Jul 22, 20264572439899!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $1.8K
- Period of performance
- Jul 21, 2026 – Jul 22, 2026
SPE2D326F276R
Completed: Period of performance ended Jul 21, 20264572439900!GRISEOFULVIN ULTRA 250 MG TAB 100S
Department of Defense · Defense Logistics Agency
- Obligated
- $979.4
- Period of performance
- Jul 20, 2026 – Jul 21, 2026
SPE2D326F268T
Completed: Period of performance ended Jul 16, 20264572400142!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $440.6
- Period of performance
- Jul 15, 2026 – Jul 16, 2026
SPE2D326F259E
Completed: Period of performance ended Jul 15, 20264572377226!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $330.5
- Period of performance
- Jul 14, 2026 – Jul 15, 2026
SPE2D326F259K
Completed: Period of performance ended Jul 15, 20264572377228!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $3.7K
- Period of performance
- Jul 14, 2026 – Jul 15, 2026
SPE2D326F259Q
Completed: Period of performance ended Jul 15, 20264572377227!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $220.3
- Period of performance
- Jul 14, 2026 – Jul 15, 2026
SPE2D326F255F
Completed: Period of performance ended Jul 14, 20264572360556!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $440.6
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
SPE2D326F256Z
Completed: Period of performance ended Jul 14, 20264572362187!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $1.1K
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
SPE2D326F257Y
Completed: Period of performance ended Jul 14, 20264572362185!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $110.2
- Period of performance
- Jul 13, 2026 – Jul 14, 2026
SPE2D326F235P
Completed: Period of performance ended Jul 6, 20264572289674!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $220.3
- Period of performance
- Jul 2, 2026 – Jul 6, 2026
SPE2D326F232S
Completed: Period of performance ended Jul 2, 20264572279262!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $367
- Period of performance
- Jul 1, 2026 – Jul 2, 2026
SPE2D326F233H
Completed: Period of performance ended Jul 2, 20264572279261!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $110.2
- Period of performance
- Jul 1, 2026 – Jul 2, 2026
SPE2D326F233R
Completed: Period of performance ended Jul 2, 20264572279260!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $440.6
- Period of performance
- Jul 1, 2026 – Jul 2, 2026
SPE2D326F233S
Completed: Period of performance ended Jul 2, 20264572279259!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $2.8K
- Period of performance
- Jul 1, 2026 – Jul 2, 2026
SPE2D326F234D
Completed: Period of performance ended Jul 2, 20264572279745!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $330.5
- Period of performance
- Jul 1, 2026 – Jul 2, 2026
SPE2D326F226B
Completed: Period of performance ended Jul 1, 20264572267719!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $330.5
- Period of performance
- Jun 30, 2026 – Jul 1, 2026
SPE2D326F220Q
Completed: Period of performance ended Jun 30, 20264572262720!ONDANSETRON ODT 4 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $110.2
- Period of performance
- Jun 29, 2026 – Jun 30, 2026
SPE2D326F221L
Completed: Period of performance ended Jun 30, 20264572262721!ONDANSETRON ODT 8 MG TABLET 30S
Department of Defense · Defense Logistics Agency
- Obligated
- $734
- Period of performance
- Jun 29, 2026 – Jun 30, 2026
SPE2D326F214H
Completed: Period of performance ended Jun 25, 20264572221687!DOXYCYCLINE HYCLATE 100 MG TAB 1000S
Department of Defense · Defense Logistics Agency
- Obligated
- $233.7
- Period of performance
- Jun 24, 2026 – Jun 25, 2026
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75A50326C00010 BULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (CHARTWELL RX, LLC) | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $21.9M | Sep 30, 2026 – Sep 29, 2027 | Recompete 6–12 mo: Potential end Sep 29, 2027 (10 months away)AI brief for award 75A50326C00010Bid team for the recompete of award 75A50326C00010 |
75A50325F80009 under 36F79720D0198 DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $144.6M | Jun 23, 2025 – Jun 22, 2027 | Recompete 6–12 mo: Potential end Jun 22, 2027 (7 months away)AI brief for award 75A50325F80009Bid team for the recompete of award 75A50325F80009 |
SPE2D026F0099 under SPE2D020D0005 8511936905!OTHER MEDICAL | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $648.6K | Feb 27, 2026 – Apr 19, 2027 | Recompete < 6 mo: Potential end Apr 19, 2027 (5 months away)AI brief for award SPE2D026F0099Bid team for the recompete of award SPE2D026F0099 |
75A50325C00012 BULK PHARMA - GROUP A (ASSET MGMT) DOXYCYCLINE 25MG/5ML ORAL SUSPENSION, POWDER, 60ML BOTTLE, ONDANSETRON HCL 8MG, 30 TABLETS, BOTTLE | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325412 · 6505DRUGS AND BIOLOGICALS | $16.1M | Sep 1, 2025 – Aug 31, 2026 | Completed: Period of performance ended Aug 31, 2026 |
SPE2D326F287Q under SPE2D020D0005 4572451958!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $550.8 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F289E under SPE2D020D0005 4572455482!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $550.5 | Jul 22, 2026 – Jul 23, 2026 | Completed: Period of performance ended Jul 23, 2026 |
SPE2D326F282N under SPE2D020D0005 4572439899!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $1.8K | Jul 21, 2026 – Jul 22, 2026 | Completed: Period of performance ended Jul 22, 2026 |
SPE2D326F276R under SPE2D020D0005 4572439900!GRISEOFULVIN ULTRA 250 MG TAB 100S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $979.4 | Jul 20, 2026 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
SPE2D326F268T under SPE2D020D0005 4572400142!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $440.6 | Jul 15, 2026 – Jul 16, 2026 | Completed: Period of performance ended Jul 16, 2026 |
SPE2D326F259E under SPE2D020D0005 4572377226!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $330.5 | Jul 14, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
SPE2D326F259K under SPE2D020D0005 4572377228!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $3.7K | Jul 14, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
SPE2D326F259Q under SPE2D020D0005 4572377227!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $220.3 | Jul 14, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
SPE2D326F255F under SPE2D020D0005 4572360556!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $440.6 | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
SPE2D326F256Z under SPE2D020D0005 4572362187!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $1.1K | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
SPE2D326F257Y under SPE2D020D0005 4572362185!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $110.2 | Jul 13, 2026 – Jul 14, 2026 | Completed: Period of performance ended Jul 14, 2026 |
SPE2D326F235P under SPE2D020D0005 4572289674!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $220.3 | Jul 2, 2026 – Jul 6, 2026 | Completed: Period of performance ended Jul 6, 2026 |
SPE2D326F232S under SPE2D020D0005 4572279262!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $367 | Jul 1, 2026 – Jul 2, 2026 | Completed: Period of performance ended Jul 2, 2026 |
SPE2D326F233H under SPE2D020D0005 4572279261!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $110.2 | Jul 1, 2026 – Jul 2, 2026 | Completed: Period of performance ended Jul 2, 2026 |
SPE2D326F233R under SPE2D020D0005 4572279260!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $440.6 | Jul 1, 2026 – Jul 2, 2026 | Completed: Period of performance ended Jul 2, 2026 |
SPE2D326F233S under SPE2D020D0005 4572279259!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $2.8K | Jul 1, 2026 – Jul 2, 2026 | Completed: Period of performance ended Jul 2, 2026 |
SPE2D326F234D under SPE2D020D0005 4572279745!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $330.5 | Jul 1, 2026 – Jul 2, 2026 | Completed: Period of performance ended Jul 2, 2026 |
SPE2D326F226B under SPE2D020D0005 4572267719!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $330.5 | Jun 30, 2026 – Jul 1, 2026 | Completed: Period of performance ended Jul 1, 2026 |
SPE2D326F220Q under SPE2D020D0005 4572262720!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $110.2 | Jun 29, 2026 – Jun 30, 2026 | Completed: Period of performance ended Jun 30, 2026 |
SPE2D326F221L under SPE2D020D0005 4572262721!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $734 | Jun 29, 2026 – Jun 30, 2026 | Completed: Period of performance ended Jun 30, 2026 |
SPE2D326F214H under SPE2D020D0005 4572221687!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense · Defense Logistics Agency | 325411 · 6505DRUGS AND BIOLOGICALS | $233.7 | Jun 24, 2026 – Jun 25, 2026 | Completed: Period of performance ended Jun 25, 2026 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with CHARTWELL RX LLC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.